Huons Biopharma Appoints Junghee Lee as New CEO
"Accelerating Overseas Market Expansion as Exports to China Begin in Earnest"
Huons Biopharma, a subsidiary of Huons Group specializing in botulinum toxin, announced on April 14 that Junghee Lee has been appointed as its new CEO.
The newly appointed CEO, Junghee Lee, born in 1976, holds an MBA from Aalto University in Finland (formerly Helsinki School of Economics). Over the past 23 years, Lee has built expertise in marketing, sales, and strategic planning in the dermatological and aesthetic medicine markets, having worked at Ipsen Korea, Hanwha Pharm, Hugel, Daewoong Pharmaceutical, Jetema, and Chong Kun Dang Bio. While at Hugel and Daewoong Pharmaceutical, Lee was in charge of overseas business development and is credited with laying the foundation for global market expansion.
In January, Huons Biopharma received product approval from the National Medical Products Administration (NMPA) of China for its botulinum toxin, Hutox® (marketed domestically as Liztox·LIZTOX®) in the 100-unit dosage, and began its first shipments last month.
CEO Lee stated, "Huons Biopharma is at a critical juncture as we have obtained product approval for our botulinum toxin in China and are beginning to accelerate exports. In the second half of this year, we will actively pursue exports to China and expand research and development for next-generation products, making every effort to ensure sustainable growth."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Huons Biopharma currently sells its products in 16 countries, including Thailand and Russia. The company plans to further expand its global sales, focusing on South America, the Middle East, and Southeast Asia.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.